An event of the off-label use of an amplatzer pfo, heart block, and removal of the device was reported.The results of the investigation are inconclusive since the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications at the time of commercialization.Based on the information received, the cause of the reported incident could not be conclusively determined.Please note per the instructions for use, artus600609-001 revision d "the amplatzer¿ pfo occluder is indicated for percutaneous transcatheter closure of a patent foramen ovale (pfo)." and "the safety and effectiveness of the amplatzer¿ pfo occluder has not been established in patients with age less than 18 years or greater than 60 years.".
|
On (b)(6) 2019, the patient was evaluated for atrial septal defect closure.The physician had initially intended to use a non-abbott gore occluder, but the user elected to forgo that device due to the less than favorable wire position.A 25 mm amplatzer pfo occluder was then selected, for off-label use.The device was successfully positioned, deployed, and released, but immediately following the release the patient developed 3rd degree heart block.The user decided to remove the device.While prepping the snare, the heart rhythm changed to 2nd degree heart block for which medication was administered.Then while attempting to snare the device the patient reverted to normal sinus rhythm.It was then decided to leave the device in place; however, that evening the patient went into 2nd degree heart block.The following morning, the device was successfully snared and the patient reverted back to sinus rhythm.
|